SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 237 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $213,000 | -59.0% | 7,751 | -50.6% | 0.00% | -66.7% |
| Q2 2019 | $520,000 | -35.6% | 15,701 | -31.8% | 0.00% | -40.0% |
| Q1 2019 | $807,000 | -10.2% | 23,038 | -14.9% | 0.01% | -16.7% |
| Q4 2018 | $899,000 | +11.3% | 27,063 | +68.7% | 0.01% | +50.0% |
| Q3 2018 | $808,000 | -29.4% | 16,039 | -16.1% | 0.00% | -42.9% |
| Q2 2018 | $1,144,000 | +20.2% | 19,108 | -20.0% | 0.01% | +40.0% |
| Q4 2017 | $952,000 | +4.0% | 23,887 | +4.4% | 0.01% | 0.0% |
| Q3 2017 | $915,000 | – | 22,880 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |